Green tea polyphenols are known to protect allogenic donor tissues from acute rejection by their recipients. This immunosuppressive effect may be generated by a unique chemical property of the major component, epigallocatechin-o-gallate (EGCG), which can block specific cell surface molecules of the donor tissues. To test this hypothesis, we examined the effects of EGCG on the murine mixed lymphocyte reactions. EGCG treatment of stimulator cells significantly attenuated the proliferation of responder T cells. The proliferation did not recover upon the secondary stimulations by fresh untreated cells or exogenous IL-2. Flow cytometric analyses showed that EGCG treatment decreased the staining intensities of various cell surface molecules including MHC II, which plays a major role in antigen presentation, and B7.1, B7.2, and their ligand, CD28, which are required for costimulatory signals in T-cell activation. These results suggest that an anergic state of alloreactive T cells may be induced by either weakening of antigen signaling or blockage of costimulatory signals with EGCG. Other possible mechanisms behind the immunosuppressive effect and a potential use of EGCG treatment of donor tissues in transplantation medicine are discussed.
INTRODUCTION
cules that are involved in antigen recognition and interfere with the recognition of a donor tissue as foreign by its recipient. In the present study, we tested this hypotheStudies on transplantation immunology have shown that some plant-derived chemicals can prevent transsis by examining the influence of (−)-epigallocatechino-gallate (EGCG), a major green tea polyphenol compoplantation-associated problems such as graft rejection and graft versus host disease (GVHD) (5,19,21). Among nent, on various parameters of allostimulation using a murine mixed lymphocyte culture (MLR) system. these chemicals, green tea polyphenols, better known as anti-cell proliferation agents, were recently found to prevent allogenic rejection of nerve transplants in rats, MATERIALS AND METHODS where immersing peripheral nerve bundles in a polyMice phenol solution before transplantation completely avoided rejection by the host (7). This process should involve Female BALB/c and C57Bl/6 mice were purchased from Japan SLC (Shizuoka, Japan) and housed under immunological interactions between the polyphenoltreated donor tissue and the host immune cells but not a specific pathogen-free conditions. Mice were used at the age of 9-11 weeks old. All experiments were approved direct proliferation arrest of the latter, which is not treated with polyphenols.
by the local review board of Kyoto University and were conducted in accordance with the national and internaThe exact mechanism of this immunosuppressive effect and a specific active component of the polyphenols tional guidelines for laboratory animal care.
have not yet been defined (21). Because the polyphenols EGCG Treatment Protocol are known to bind to cell surface macromolecules (12) and impair receptor-ligand interactions (2), we hypotheSpleens were aseptically removed from BALB/c (H-2K d ) and C57Bl/6 (H-2K b ) female mice, and cell suspensized that they would attach to such cell surface mole- sions were prepared by teasing and flushing the spleens clonal anti-mouse CD/MHC antibodies and corresponding isotype-matched control antibodies. These antibodies with forceps and filtering through a 50-µm filter in Hank's balanced salt solution (HBSS) containing 1% are to detect CD28, CD49d, B7.1 (CD80), B7.2 (CD86), MHC I, MHC II (eBioscience), and TCRαβ (Phar-FCS. Cells were centrifuged at 300 × g for 5 min, resuspended in 10 ml RPMI-1640 (Sigma-Aldrich, Tokyo, mingen, San Diego, CA). The splenocytes were treated with red blood cell lysis buffer (eBioscience) for 5 min, Japan) containing 0, 200, or 400 µM EGCG/10 7 cells, and incubated at 4°C for 1 h. After incubation, cells and mononuclear cells were treated with EGCG-containing media and washed with RPMI (10% FCS) and a were immediately washed twice with RPMI-1640 (10% FCS) before being used in mixed lymphocyte reactions staining buffer (eBioscience) at 4°C. Each splenocyte sample was reconstituted in 50 µl of the staining buffer or cell surface marker analyses. and subjected to antibody labeling for 15 min. After Mixed Lymphocyte Reaction (MLR) washing the samples twice with the staining buffer, a minimum of 10,000 events per sample was collected and Splenocytes derived from BALB/c mice were used as "stimulator" cells and those from C57Bl/6 as "responder" analyzed on a FACScan flow cytometer (Becton Dickinson, Franklin Lakes, NJ). cells. In both one-way and two-way MLRs, the stimulator cells were untreated or treated with EGCG FACScan. FCS, 100 U/ml penicillin, and 100 ppm streptomycin) to a final concentration of 5.0 × 10 6 cells/ml. The stimuDetection of Apoptosis by Flow Cytometry lator and responder cells were mixed at a 1:1 ratio (100 To examine whether apoptosis is induced in the resµl each) in 96-well microplates and incubated triplicate ponder and EGCG-treated stimulator cells in MLR culat 37°C with 5% CO 2 for 72 h. Cell proliferation was ture, apoptosis was examined by flow cytometry. Cells assessed by counting an aliquot of harvested cells from collected from MLR plates after 24 h of incubation were each MLR well with a trypan-blue exclusion method.
washed once with PBS. The cells were stained with PEMeasurement of IL-2 labeled anti-mouse H-2K b monoclonal antibody (Caltag Laboratories, CA), which stains the responder cells After the period of MLR incubation, supernatants (C57Bl/6). Then apoptotic cells were stained with FITCfrom the cultures were assayed for IL-2 production uslabeled Annexin V according to the manufacturer's ing cytokine quantification ELISA kits according to instructions (R&D Systems, MN) and analyzed on manufacturer's instruction (eBioscience, San Diego, FACScan. CA). The detection limit of IL-2 was 10 pg/ml.
Statistical Analysis Secondary Stimulation of MLR Cultures
All results are expressed as mean ± SD. Differences One-way MLR wells were separately prepared, and between the experimental groups of triplicate samples after 48 h of incubation the cells were recultured with were analyzed by ANOVA and Fisher's PLSD using MMC-treated fresh BALB/c splenocytes (5.0 × 10 6 cells/ StatView (SAS Institute Inc., Cary, NC). Values of p < ml) in complete medium. Some MLR wells were cul-0.05 were considered significant. tured with exogenous recombinant murine IL-2 (1.7 IU/ ml) (eBioscience). These MLR cultures were incubated RESULTS for an additional 48 h, and cell proliferation was asMixed Lymphocyte Reaction sessed as described earlier.
We first examined the effects of EGCG treatment on Effects of EGCG treatment on induction of one-way and two-way MLR. C57Bl/6 splenocytes were cocultured with EGCG-treated stimulator BALB/c splenocytes either treated (one-way MLR) or untreated with MMC (two-way MLR). Differences were significant between treated and untreated groups (*p < 0.0001; **p < 0.018).
tial proliferation (Fig. 1) . The proliferation was attenuway MLR cultures as detected by ELISA after 72 h of incubation (Fig. 3) . IL-2 production was also reduced in ated down to 20-30% when stimulator cells were treated with 200 or 400 µM EGCG. Microscopic images two-way MLR cultures after EGCG treatment of BALB/ c splenocytes (Fig. 3) . of MLR cultures for these cells showed the suppressed levels of foci formation (Fig. 2) . In two-way MLR, Detection of Cell Proliferation by Cytometry where both stimulator and responder cell populations are capable of proliferation, EGCG treatment similarly re-CD71, transferrin receptor, is expressed on the cell surface of actively dividing cells and has been used as sulted in the attenuated proliferation (Fig. 1) . We next examined the effects of EGCG treatment on IL-2 proan activation marker of T-cell proliferation. To examine if the proliferation of responder T cells was attenuated duction in MLR cultures and found that EGCG treatment strongly reduced the production of IL-2 in oneby coculturing with EGCG-treated stimulator cells, cells (Fig. 4) .
most of the tested cell surface molecules was reduced by EGCG treatments, and the levels of reduction appeared to vary among different surface molecules ( Table   Table 1 EGCG-untreated fresh stimulator cells or IL-2 (1.7 U/ Tissue or organ transplantation is increasingly applied for the treatment of many medical problems, but ml) and analyzed the T-cell proliferation in secondary cultures. There was significant suppression of T-cell its major drawbacks are transplant rejection and GVHD. One of the ordinary therapeutic methods to prevent these proliferation down to or below that of the unstimulated control cultures (Fig. 6) .
problems is the application of pharmacological agents that suppress T-cell activation (18) . Although these Detection of Apoptosis by Cytometry chemical agents mitigate the problems by inhibiting Tcell signaling and activation, they often cause significant To examine the proportions of apoptotic cells in responder cells (C57Bl/6) and EGCG-treated stimulator side effects on various tissues such as renal, hepatic, gastrointestinal, and mucosal systems (3). To avoid cells (BALB/c), cells from MLR cultures after 24 h were analyzed by Annexin V assay. For the responder cells these side effects, more amenable methods have been developed (10, 11, 14) . One of the promising methods is that were cocultured with the stimulator cells treated with EGCG, there was no substantial change in the proimmunocamouflage where the donor tissues bearing cell surface antigenic determinants are coated with nonimportion of apoptotic cells due to the EGCG treatment (0 µM: 81.8 ± 2.1%; 200 µM: 77.9 ± 1.1%; 400 µM: 78.7 ± munogenic agents such as polyethylene glycol (PEG) (14) . PEG can block immunogenic recognition by the 1.7%, based on one-way ANOVA of triplicate samples, F = 4.43, p > 0.05) (Fig. 7) . In contrast, for the stimulahost immune system and decrease graft rejection and GVHD (4,13). In the present study, we hypothesized tor cells, the proportion of apoptotic cells significantly decreased with the EGCG treatment (Fig. 7) .
that a tea polyphenol, EGCG, also blocks antigenic determinants and attenuates the allostimulation and subse-DISCUSSION quent activation of host T cells.
Our results indicate that responder T-cell proliferaOur present study demonstrated that EGCG can prevent allostimulation in a murine in vitro allograft contion in the MLR culture was attenuated when the stimulator cells were treated with EGCG (Fig. 1) . The EGCG text. EGCG treatment of murine splenocytes decreased the cell signaling for optimal allostimulation and attenutreatment of the stimulator cells representing the transplant led to the attenuation of T-cell proliferation of the ated the activation and proliferation of T cells in the MLR cultures.
responder cells (Fig. 4) representing the host, which is usually targeted by immunosuppressive drugs. Because the stimulator cells in one-way MLR culture had been arrested of proliferation by mitomycin C, the decrease of T-cell proliferation was largely due to the influence of EGCG on the stimulator cells and/or their stimulatory activities. The choice of C57Bl/6 as the responder rather than the stimulator in the one-way MLR in these experiments was to avoid overestimating the attenuating potential of EGCG treatment because C57Bl/6 T cells are classified as Th-1 type and are generally considered to have stronger and more sustained response toward cellular antigens than BALB/c T cells, which belong to Th-2 type. It must be noted that the decrease of T-cell proliferation was not due to the direct toxicity of EGCG on the stimulator cells. In fact, EGCG-treated stimulator cells in MLR cultures had reduced levels of apoptosis than untreated controls (Fig. 7) . For the same reason, the pro- (Fig. 3) by the EGCG-treated stimulator cells but not splenocytes for 48 h, MLR wells were restimulated with either loss of viability of the latter. IL-2 production was also fresh untreated BALB/c splenocytes (black columns) or exogenous IL-2 (hatched columns), and incubated for an additional reduced in two-way MLR cultures (Fig. 3) . In two-way 48 h. C57Bl/6 without any stimulation is shown as a back-MLR cultures, we cannot simply determine which cell ground (blank column). Differences were significant between type (C57B/6 or BALB/c) is actually contributing to IL- stimulation with EGCG-treated stimulators. These results provide further evidence to support that EGCG The T cells stimulated with EGCG-treated stimulators were not only attenuated of proliferation but rentreatment prevents acute graft rejection (7) and present a question as to what mechanisms are involved in the dered somehow unresponsive toward allostimulation (i.e., they were in an anergic state). In fact, the proliferainfluence of EGCG on the stimulator cells and their activities. tion of the responder cells did not recover upon secondary stimulation with fresh stimulator cells or even exogIn light of the present hypothesis, the simplest interpretation is that stimulatory activities were abrogated by enous IL-2 (Fig. 6) . The lack of responsiveness to the secondary stimulation with cells is not necessarily due blocking cell surface molecules with EGCG, resulting in weak or incomplete stimulation of alloreactive T cells. to the mortality of responder cells, as indicated by the result of apoptosis detection (Fig. 7) . Although T-cell Indeed, staining intensity of cell surface molecules involved in allorecognition, costimulation, and cell-to-cell apoptosis is known to be required in the induction of peripheral transplantation tolerance (20) , the level of readhesion were reduced by the EGCG treatment (Table  1) . Weakening or blockage of interactions of any of sponder cell apoptosis occurring in our experimental system suggests that the induction of anergy due to these molecules and their ligands could lead to incomplete activation of T cells (4). EGCG treatment of stimulator cells is involved in the unresponsiveness of responder T cells (Fig. 7) FurtherParticular attention is paid to the different effects exhibited among these cell surface molecules. Normally, more, the lack of responsiveness to the secondary stimu-
